Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety

Current Pharmaceutical Design

Volumn 20, Issue 29, 2014, Pages 4656-4678

  Vida, Carmen ^a   González, Eva Ma ^a   De la Fuente, Mónica ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Anxiety; Inflammation; Inmunosenescence; Neuroendocrine immune axis; Oxi inflammaging; Oxidative stress; Premature aging

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; NEUROTRANSMITTER; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

AGING; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; BECK ANXIETY INVENTORY; BRAIN CORTEX; CELL FUNCTION; CEREBELLUM; CORPUS STRIATUM; DISTRESS SYNDROME; FRONTAL CORTEX; HEART; HIPPOCAMPUS; HUMAN; IMMOBILIZATION STRESS; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE; LIPID PEROXIDATION; NERVOUS SYSTEM; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREFRONTAL CORTEX; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN CARBONYLATION; SEMINAL PLASMA; SENSITIZATION; SERUM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANXIETY; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NERVOUS SYSTEM; OXIDATIVE STRESS;

EID: 84906230096     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140130201734     Document Type: Article

References (290)

1. Franceschi C, Bonafé M, Valensin S, et al. Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254.
2. De la Fuente M, Miquel J. An update of the oxidation inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des 2009; 15: 3003-3026.
3. Kirkwood TB. Human senescence. Bioessays 1996; 8: 1009-1016.
4. De la Fuente M. Role of neuroimmunomodulation in aging. Neuro-immunomodulation 2008; 15: 213-223.
5. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 2007; 1100: 1-13.
6. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
7. Harman D. The free radical theory of aging. Antioxid Redox Signal 2003; 5: 557-561.
8. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006; 1067: 10-21.
9. Johnson FB, Sinclair DA, Guarente L. Molecular biology of aging. Cell 1999; 96: 291-302.
10. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
11. Miquel J, de Juan E, Sevila I. Oxygen-induced mitochondrial damage and aging. EXS 1992; 62: 47-57.
12. Barja G. Free radicals and aging. Trends Neurosci 2004; 27(10): 595-600.
13. Kregel CK, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects and pathological considerations. AJP Regu Physiol 2007; 292: R18-R36.
14. De la Fuente M, Hernanz A, Vallejo MC. The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise. Antioxid Redox Signal 2005; 7: 1356-1366.
15. Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues Clin Neurosci 2002; 4: 123-137.
16. Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety. Relationship and cellular pathways. Oxid Med Cell Longev 2009; 2: 663-679.
17. Steimer T. Animal models of anxiety disorders in rats and mice: some conceptual issues. Dialogues Clin Neurosci 2011; 13: 495-506.
18. Salim S. Oxidative stress in anxiety: implications for pharma-cotherapy. AJIM 2008; 1: 11-21.
19. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuro-psychopharmacol 2008; 11: 851-876.
20. Kubzansky LD, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease? J Psychosom Res 2000; 48: 323-337.
21. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB Sr, Benjamin EJ. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med 2005; 67: 692-696.
22. Benninghoven D, Kaduk A, Wiegand U, Specht T, Kunzendorf S, Jantschek G. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother Psychosom 2006; 75: 56-61.
23. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30: 208-225.
24. Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry 2009; 66: 91-93.
25. Spitzer C, Barnow S, Völzke H, John U, Freyberger HJ, Grabe HJ. Trauma, posttraumatic stress disorder and physical illness: findings from the general population. Psychosom Med 2009; 71: 1012-1017.
26. Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: The Heart and Soul Study. Arch Gen Psychiatry 2010; 67: 750-758.
27. O'Donovan A, Slavich GM, Epel ES, Neylan TC. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev 2013; 37: 96-108.
28. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153: 1194-1217.
29. Harman D. Free radical theory of aging: consequences of mito-chondrial aging. Age 1983; 6: 86-94.
30. Harman D. Aging and oxidative stress. J Int Fed Clin Chem 1998; 10: 24-27.
31. Gutteridge JM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995; 18: 125-126.
32. Halliwell B, Gutteridge JM. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum Toxicol 1988; 7: 7-13.
33. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induce-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001; 40: 959-975.
34. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997; 82: 291-295.
35. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009; 46: 531-542.
36. Fatehi-Hassanabad Z, Chan CB, Furman BL. Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 2010; 636: 8-17.
37. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
38. Brieger K, Schiavonea S, Miller FJ, Krausea KH. Reactive oxygen species: from health to disease. Swiss Med Wkly 2012; 142: w13659.
39. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
40. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-1330.
41. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
42. Hensley K, Maidt L, Stewardt CA, Pye QN, Robinson KA, Floyd RA. Mitochondrial alteration in aging and inflammation: a possible site of action of nitrone-based free radical traps. In: Cadenas E, Packer L, Eds. Understanding the process of aging the roles of mitochondria, free radicals and antioxidants. New York: Marcel Dekker 1999; pp: 311-325.
43. Miquel J, Economos AC, Fleming J, Jhonson JE. Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-591.
44. Barja G, Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 2000; 14: 312-318.
45. Mari M, Morales A, Colell A, Garcia-Ruiz C, Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 2009; 11: 2685-2700.
46. Pamplona R, Barja G. Highly resistant macromolecular components and low rate of generation of endogenous damage: two key traits of longevity. Ageing Res Rev 2007; 6: 189-210.
47. Trifunovic A, Wredenberg A, Falkenberg M et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.
48. Barros MH, Da Cunha FM, Oliveira GA, Tahara EB, Kowaltowski AJ. Yeast as a model to study mitochondrial mechanisms in ageing. Mech Ageing Dev 2010; 131: 494-502.
49. Yeum KJ, Russell RM, Aldani G. Antioxidant activity and oxidative stress: an overview. In: Aldini G, Yeum KJ, Niki E, Russell RM, Eds. Biomarkers for antioxidant defense and oxidative damage: principles and practical applications. Blackwell Publishing Ltd 2010. DOI: 10.1002/9780813814438.
50. Parks DA, Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand 1986; 548: 87-99
51. Harrison R. Structure and function of xanthine oxidoreductase: where are we know? Free Radic Biol Med 2002; 6: 774-796.
52. Parks DA, Skinner KA, Skinner HB, Tan S. Multiple organ dysfunction syndrome: role of xanthine oxidase and nitric oxide. Pathophysiology 1998; 5: 49-66.
53. Sastre J, Pallardó FV, Viña J. The role of mitocondrial oxidative stress in aging. Free Radic Biol Med 2003; 35: 1-8.
54. Gibbings S, Elkins NS, Fitzgerald H, et al. Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-y sumoylation and HIF-1a. J Biol Chem 2011; 286: 961-975.
55. Harrison R. Physiological roles of xanthine oxidorreductase. Drug Metab Rev 2004; 36: 363-375.
56. Chung HY, Song SH, Kim HJ, Ikeno Y, Yu BP. Modulation of renal xanthine oxidoreductase in aging: gene expression and reactive oxygen species generation. J Nutr Health Aging 1999; 3: 19-23.
57. Newaz MA, Yousefipuour Z, Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol 2006; 48: 88-94.
58. Aranda R, Doménech E, Rus AD, et al. Age-related increase in xanthine oxidase activity in human plasma and rat tissues. Free Radic Res 2007; 41: 1995-2000.
59. Arranz L, Caamaño JH, Lord JM, De la Fuente M. Preserved immune functions and controlled leukocyte oxidative stress in naturally long-lived mice: possible role of nuclear factor kappa p. J Gerontol A Biol Sci Med Sci 2010; 65A: 941-950.
60. Vida C, Corpas I, De la Fuente M, González EM. Age-related changes in xanthine oxidase activity and lipid peroxidation, as well as in the correlation between both parameters, in plasma and several organs from female mice. J Physiol Biochem 2011; 67(4): 551-558.
61. Puca AA, Carrizzo A, Ferrario A, Villa F, Vecchione C. Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity. Immun Ageing 2012; 9: 26.
62. Park JB. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med 2003; 35: 325-335.
63. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 23-28.
64. Robinson JM. Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol 2008; 130: 281-297.
65. Robinson JM, Ohira T, Badwey JA. Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics and microscopy. Histochem Cell Biol 2004; 122: 293-304.
66. Robinson JM, Badwey JT. The NADPH oxidase complex of phagocytic leukcoytes: a biochemical and cytochemical view. Histochemistry 1995; 103: 163-180.
67. Harrison JE, Schoultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol chem 1976; 251: 1371-1374.
68. Xie Q, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthetase from mouse macrophages. Science 1992; 256: 225-228.
69. Steinbeck MJ, Khan AU, Kamavsly MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267: 13425-13433.
70. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. JASN 2003; 14: S221-S226.
71. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signalling. Cardiovasc Res 2004; 91: 21-27.
72. Schröder P, Krutmann J. Environmental Oxidative Stress -Environmental Sources of ROS. In: The Handbook of Environmental Chemistry. Berlin/Heidelberg: Springer 2005; pp: 19-31.
73. Fridovich I. The biology of oxygen radicals. Science 1978; 201: 875-880.
74. Harris ED. Regulation of antioxidant enzymes. FASEB J 1992; 6: 2675-2683.
75. Pollack M, Leeuwenburgh C. Molecular mechanism of oxidative stress in aging: free radicals, aging, antioxidants and disease. In: Sen CK, Packer L, Hinninen O, Eds. Handbook of oxidants and antioxidants in exercise. Florida: Elsevier Science 1999; pp: 881-923.
76. Bai J, Cederbaum AI. Mitochondrial catalase and oxidative injury. Biol Signals Recept 2001; 10: 189-199.
77. Tian L, Cai Q, Wei H. Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. Free Radic Biol Med 1998; 24: 1477-1484.
78. Sastre J, Pallardó FV, Viña J. Glutathione, oxidative stress and aging. AGE 1996; 19: 129-139.
79. Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000; 267: 6102-6109.
80. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74(1): 139-162.
81. Stadtman ER. Role of oxidant species in aging. Curr Med Chem 2004; 11: 1105-1112.
82. Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 2002; 397: 377-383.
83. Knight JA. Review: free radicals, antioxidants, and immune system. Ann Clin Lab Sci 2000; 30: 145-158.
84. Yoon SO, Yun ChH, Cheng AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 2002; 50: 1-8.
85. Allen RG. Oxidative stress and superoxide dismutase in development, aging and gene regulation. Age 1998; 21(2): 47-76.
86. Cao W, Carney JM, Duchon A, Floyd RA, Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosc Lett 1988; 88: 233-238.
87. Bedard K, Attar H, Bonnefont J, et al. Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum Mutat 2009; 30(7): 1123-1133
88. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 73-80.
89. Vadasz Z, Haj T, Kessel A, Toubi E. Age-related autoimmunity. BMC Medicine 2013; 11: 94.
90. Hold GL, El-Omar ME. Genetic aspects of inflammation and cancer. Biochem J 2008; 410: 225-235.
91. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007; 121: 2381-2386.
92. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage and repair. Langenbecks Arch Surg 2006; 391: 499-510.
93. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008; 11: 1-15.
94. Ryan KA, Smith MF, Sanders MK, Ernst PB. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa p and interleukin-8 expression. Infect Immun 2004; 72: 2123-2130.
95. Cannizzo ES, Clement CC, Sahua CR, Folloa C, Santambrogioa L. Oxidative stress, inflamm-aging and immunosenescence. J Pro-teomics 2011; 74: 2313-2323.
96. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med 2010; 48: 1121-1132.
97. Lotze MT, Zeh HJ, Rubartelli A, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007; 220: 60-81.
98. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
99. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140.
100. Cowan KJ, Diamond MI, Welch WJ. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum Mol Genet 2003; 12: 1377-1391.
101. Raghavan S, Subramaniyam G, Shanmugam N. Proinflammatory effects of malondialdehyde in lymphocytes. J Leukoc Biol 2012; 92: 1055-1067.
102. Luévano-Contreras C, Garay-Sevilla ME, Wrobel K, Malacara JM, Wrobel K. Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus. J Clin Biochem Nutr 2013; 52: 22-26.
103. Hung LF, Huang KY, Yang DH, Chang DM, Lai JH, Ho LJ. Advanced glycation end products induce T cell apoptosis: involvement of oxidative stress, caspase and the mitochondrial pathway. Mech Aging Dev 2010; 131: 682-691.
104. Csiszar A, Wang M, Lakatta E, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kB. Int J Mol Sci 2010; 11: 1509-1526.
105. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
106. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
107. Meng SJ, Yu LJ. Oxidative Stress, molecular inflammation and sarcopenia. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 73-80.
108. Carmeli E, Imam B, Bachar A, Merrick J. Inflammation and oxidative stress as biomarkers of premature aging in persons with intellectual disability. Res Dev Disabil 2012; 33: 369-375.
109. Fabris N. A neuroendocrine-immune theory of aging. Int J Neuro-sci 1990; 51: 373-375.
110. Gemma C. Neuroimmunomodulation and Aging. Aging Dis 2010; 1: 169-172.
111. Arranz L, Lord JM, De la Fuente M. Preserved ex vivo inflammatory status and cytokine responses in naturally long-lived mice. Age 2010; 32: 451-466.
112. Alonso-Fernández P, De la Fuente M. Role of the immune system in aging and longevity. Curr Aging Sci 2011; 4: 78-100.
113. Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD. NF-kP in aging and disease. Aging Dis 2011; 2: 449-465.
114. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-k3 signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008; 7: 83-105.
115. Schreck R, Albermann K, Baeuerle PA, Nuclear factor kappa P: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad Res Commun 1992; 17: 221-237.
116. Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-kB signalling and inflammation: impact on healthspan and lifespan. J Mol Med 2011; 89: 667-676.
117. Adler A, Sinha S, Kawahara TLA, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-kP activity. Genes Dev 2007; 21: 3244-3257.
118. Spencer NFL, Poynter ME, Im SY, Dynes RA. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 1997; 9: 1581-1588.
119. Flirski M, Sobow T. Biochemical markers and risk factors of Alzheimer's disease. Curr Alzheimer Res 2005; 2: 47-64.
120. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr, 2009; 83: 447S-455S.
121. Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 2010; 13: 97-104.
122. Espino J, Pariente JA, Rodríguez AB. Oxidative stress and immunosenescence: therapeutic effects of melatonin. Oxid Med Cell Long 2012; 670294, doi: 10.1155/2012/670294.
123. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol 2004; 16: 151-156.
124. Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A. Is immunosenescence infectious? Trends Immunol 2004; 25: 406-410.
125. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 1990; 45: M45-M48.
126. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995; 16: 12-16.
127. Franceschi C, Monti D, Barbieri E, et al. Immunosenescence in humans: deterioration or remodelling? Int Rev Immunol 1995; 12: 57-74.
128. Nomellini V, Gomez C, Kovacs E. Aging and impairment of innate immunity. Contrib Microbiol 2008; 15: 188-205.
129. Fujimoto H, Kobayashi H, Ohno M. Age-induced reduction in mitochondrial manganese superoxide dismutase activity and tolerance of macrophages against apoptosis induced by oxidized low density lipoprotein. Circulation Journal 2010; 74: 353-360.
130. Miyaji C, Watanabe H, Toma H, et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol 2000; 61: 908-916.
131. Larbi A, Kempf J, Pawelec G. Oxidative stress modulation and T cell activation. Exp Gerontol 2007; 42: 852-858.
132. Ponnappan S, Ovaa H, Ponnappan U. Lower expression of catalytic and structural subunits of the proteasome contributes to decreased proteolysis in peripheral blood T lymphocytes during aging. Int J Biochem Cell Biol 2007; 39: 799-809.
133. Espino J, Bejarano I, Paredes SD, et al. Melatonin counteracts alterations in oxidative metabolism and cell viability induced by intracellular calcium overload in human leucocytes: changes with age. Basic Clin Pharmacol Toxicol 2010; 107: 590-597.
134. Rich EA, Mincek MA, Armitage KB, et al. Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen. Gerontology 1993; 39: 93-108.
135. Rodier F, Coppé JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973-979.
136. Mariani E, Pulsatelli L, Meneghetti A, et al. Different IL-8 production by T and NK lymphocytes in elderly subjects. Mech Ageing Dev 2001; 122(13): 1383-1395.
137. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev, 1999; 108: 1-7.
138. Huffman DM, Moellering DR, Grizzle WE, Stockard CR, Johnson MS, Nagy TR. Effect of exercise and calorie restriction on bio-markers of aging in mice. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1618-R1627.
139. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429: 883-891.
140. Gemma C, Vila J, Bachstetter A, Bickford PC. Oxidative stress and the aging brain: from theory to prevention. In: Riddle DR, Eds. Brain Aging: Models, Methods and Mechanisms. Boca Raton (FL): CRC Press 2007; NKB3869.
141. Mecocci P, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993; 34: 609-616.
142. Richter C, Park JW, Ames BN. Normal oxidative damage to mito-chondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988; 85: 6465-6467
143. Barja G. Free radicals and aging. Trends Neurosci 2004; 27: 595-600.
144. Yoneda M, Katsumata K, Hayakawa M, Tanaka M, Ozawa T. Oxygen stress induces an apoptotic cell death associated with fragmentation of mitochondrial genome. Biochem Biophys Res Commun 1995; 209: 723-729.
145. Chomyn A, Attardi G. MtDNA mutations in aging and apopto-sis. Biochem Biophys Res Commun 2003; 304: 519-529.
146. Ikebe S, Tanaka M, Ohno K, et al. Increase of deleted mitochon-drial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990; 170: 1044-1048.
147. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genom-ics1994; 23: 471-476.
148. Horton TM, Graham BH, Corral-Debrinski M, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients. Neurology 1995; 45: 1879-1883.
149. Pamplona R, Barja G, Portero-Otín M. Membrane fatty acid un-saturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation? Ann N Y Acad Sci 2002; 959: 475-490
150. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002; 23: 795-807.
151. Arranz L, Naudí A, De la Fuente M, Pamplona R. Exceptionally old mice are highly resistant to lipoxidation-derived molecular damage. AGE 2013; 35: 621-635.
152. Spiteller G. Is lipid peroxidation of polyunsaturated acids the only source of free radicals that induce aging and age-related diseases? Rejuvenation Res 2010; 13: 91-103.
153. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
154. Cini M, Moretti A. Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol Aging 1995; 16: 53-57.
155. Dei R, Takeda A, Niwa H, et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berl.) 2002; 104: 113-122.
156. Gemma C, Mesches MH, Sepesi B, Choo K, Holmes DB, Bickford PC. Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci 2002; 22: 6114-6120.
157. Cakatay U, Telci A, Kayalì R, Tekeli F, Akçay T, Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp Gerontol 2001; 36: 221-229.
158. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxida-tion, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 1997; 68: 255-264.
159. Butterfield DA, Hensley K, Cole P, et al. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 1997; 68: 2451-2457.
160. +/KATPase. Free Radic Biol Med 1996; 20: 215-223.
161. Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 2003; 24: 293-303.
162. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996; 93: 2696-2701.
163. Markesbery WR, Lovell M. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neu-robiol Aging 1998; 19: 33-36.
164. Montine KS, Reich E, Neely MD, et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 1998; 57: 415-425.
165. Papaioannou N, Tooten PC, van Ederen AM, et al. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 2001; 8: 11-21.
166. Smith CD, Carney JM, Starke-Reed PE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991; 88: 10540-10543.
167. Aksenova MV, Aksenov MY, Carney JM, Butterfield DA. Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing Dev 1998; 100: 157-168.
168. Nicolle MM, Gonzalez J, Sugaya K, et al. Signatures of hippocam-pal oxidative stress in aged spatial learning-impaired rodents. Neuroscience 2001; 107: 415-431.
169. Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 1999; 20: 395.
170. Shin CM, Chung YH, Kim MJ, Lee EY, Kim EG, Cha CI. Age-related changes in the distribution of nitrotyrosine in the cerebral cortex and hippocampus of rats. Brain Res 2002; 931: 194.
171. Naudi A, Jove M, Ayala V, Portero-Otin M, Barja G, Pamplona R. Regulation of membrane unsaturation as antioxidant adaptive mechanism in long-lived animal species. Free Radic Antiox 2011; 1: 3-12.
172. Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004; 58: 39-46.
173. Stranahan AM, Mattson MP. Recruiting adaptive cellular stress responses for successful brain ageing. Nat Rev Neurosci 2012; 13: 209-216.
174. Sobocanec S, Balog T, Kusic B, Sverko V, Saric A, Marotti T. Differential response to lipid peroxidation in male and female mice with age: correlation of antioxidant enzymes matters. Biogerontol-ogy 2008; 9: 335-343.
175. Carrillo MC, Kanai S, Sato Y, Ivy GO, Kitani K. Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats. Biochem Pharmacol 1992; 44: 2185-2189.
176. Ciriolo MR, Marasco MR, Iannone M, Nisticó G, Rotilio G. Decrease of immunoreactive catalase protein in specific areas of ageing rat brain. Neurosci Lett 1997; 228: 21-24.
177. Venkateshappa C, Harish G, Mahadevan A, Srinivas Bharath MM, Shankar SK. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochem Res 2012; 37: 1601-1614.
178. Posadas SJ, Caz V, Largo C, et al. Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp Gerontol 2009; 44: 383-389.
179. Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995; 45: 1594-1601.
180. Fischer HG, Morawski M, Brückner MK, Mittag A, Tarnok A, Arendt T. Changes in neuronal DNA content variation in the human brain during aging. Aging Cell 2012; 11: 628-633.
181. Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitized the brain to the effects of infection or stress. Neu-roimmunomodulation 2008; 15: 323-330.
182. Gemma C, Bachstetter AD, Bickford PC. Neuron-microglia dialogue and hippocampal neurogenesis in the aged brain. Aging Dis 2010; 3: 232-244.
183. Aloisi F. Immune function of microglia. Glia 2001; 36: 165-179.
184. Batchelor PE, Liberatore GT, Wong JY, et al. Activated macro-phages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 1999; 19: 1708-1716.
185. Floyd RA. Neuroinflammatory processes are important in neurode-generative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic Biol Med 1999; 26: 1346-1355.
186. Chang JY, Liu LZ. Manganese potentiates nitric oxide production by microglia. Brain Res Mol Brain Res 1999; 68: 22-28.
187. Dringen R. Oxidative and antioxidative potential of brain micro-glial cells. Antioxid Redox Signal 2005; 7: 1223-1233.
188. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response: The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 1998; 851: 311-335.
189. Moynihan JA. Mechanisms of stress-induced modulation of immunity. Brain Behav Immun 2003; 17 (Suppl 1): S11-S16.
190. Weinberger DR. Anxiety at the frontier of molecular medicine. N Engl J Med 2001; 344: 1247-1249.
191. Gorman JM, Kent JM, Coplan, JD. Current and emerging therapeutics of anxiety and stress disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C, Eds. Neuropsychopharmacology: The Fifth Generation of Progress. Baltimore, MD: Lippincott Williams & Wilkins 2002; pp: 967-980.
192. Belzung C, Griebel G. Measuring normal and pathological anxietylike behaviour in mice: a review. Behav Brain Res 2001; 125: 141-149.
193. Gingrich, JA. Oxidative stress is the new stress. Nat Med 2005; 11: 1281-1282.
194. Mathew SJ, Price RB, Charney DS. Recent advances in the neuro-biology of anxiety disorders: Implications for novel therapeutics. Am J Med Genet C 2008; 148: 89-98.
195. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and co-morbid disorders. Neurosc Res, 2010; 68: 261-275.
196. Bouayed J, Bohn T. Exogenous antioxidants- double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 2010; 3: 228-237.
197. Bouayed J. Relationship between oxidative stress and anxiety: emerging role of antioxidants within therapeutic or preventive approaches. In: Kalinin V, Eds. Mental and behavioural disorders and diseases of the nervous system: anxiety disorders. InTech 2011; pp: 27-38.
198. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006. 97: 1634-1658
199. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
200. Hovatta I, Tennant RS, Helton R, et al. Glyoxilase I and glu-tathione reductase 1 regulate anxiety in mice. Nature, 2005; 438: 662-666.
201. Landgraf R, Kessler MS, Bunck M, et al. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vaso-pressin and glyoxalase-I. Neurosci Biobehav Rev 2007; 1: 89-102.
202. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdale. Nat Rev Neurosci 2009; 10: 423-433.
203. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005; 54(5 Suppl 1): 20-23.
204. Souza CG, Moreira JD, Siqueira IR, et al. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci 2007; 3: 198-203.
205. De Oliveira MR, Silvestrin RB, Mello E, Souza T, Moreira JC. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neuro-toxicology 2007; 6: 1191-1199.
206. Masood A, Nadeem A, Mustafa SJ, O'Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodi-esterase-2 in mice. J Pharmacol Exp Ther 2008; 2: 369-379.
207. Salim S, Sarraj N, Taneja M, Saha K, Tejada-Simon MV, Chugh G. Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behaviour in rats. Behav Brain Res 2010; 208: 545-552.
208. Ramal H, Bouyed J, Younos C, Soulimani R. The impact of high anxiety levels on the oxidative stratus of mouse peripheral blood lymphocytes, granulocytes and monocytes. Eur J pharmacol 2008; 589: 173-175.
209. Arranz L, Guayerbas N, De la Fuente M. Impairment of several immune functions in anxious women. J Psychosom Res 2007; 62: 1-8.
210. Rammal H, Bouayed J, Younos C, Soulimani R. Evidence that oxidative stress is linked to anxiety-related behaviour in mice. Brain Behav Immun 2008; 22: 1156-1159.
211. Lucca G, Comim CM, Valvassori SS, et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int 2009; 54: 358-362.
212. Herken H, Akyol O, Yilmaz HR et al. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 2006; 21: 53-59.
213. Miller CS. Are we on the threshold of a new theory disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicology and Industrial Health 1999; 15: 284-294.
214. Pall ML, Satterlee JD. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder. Ann N Y Acad Sci 2001; 933: 323-329.
215. Bouayed J, Rammal H, Younos C, Soulimani R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol 2007; 564: 146-149.
216. Matsumoto K, Yobimoto K, Huong NT, Abdel-Fattah M, Van Hien T, Watanabe H. Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice. Brain Res 1999; 839: 74-84.
217. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 2004; 175: 494-502.
218. Djordjevic A, Adzic M, Djordjevic J, Radojcic MB. Chronic social isolation is related to both upregulation of plasticity genes and initiation of proapoptotic signaling inWistar rat hippocampus. J Neural Transm 2009; 116: 1579-1589.
219. Sahin E, Gumuslu S. Alterations in brain antioxidant status, protein oxidation and lipid peroxidation in response to different stress models. Behav Brain Res 2004; 155: 241-248.
220. Lucca G, Comim CM, Valvassori SS, et al. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res 2009; 43: 864-869
221. Eren I, Naziroglu M, Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 2007; 32: 1188-1195.
222. Atif F, Yousuf S, Agrawal SK. Restraint stress-induced oxidative damage and its amelioration with selenium. Eur J Pharmacol 2008; 600: 59-63.
223. Zafir A, Banu N. Modulation of in vivo oxidative status by exogenous corti-costerone and restraint stress in rats. Stress 2009; 12: 167-177.
224. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
225. Eskiocak S, Gozen AS, Kilic AS, Molla S. Association between mental stress & some antioxidant enzymes of seminal plasma. Indian J. Med. Res 2005; 122: 491-496.
226. Liu J, Wang X, Shigenaga MK, Yeo HC, Mori A, Ames BN. Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. Faseb J 1996; 10: 1532-1538.
227. Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res 2001; 92: 367-376.
228. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
229. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Solda-tos C, Ste-fanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA Study. Atherosclerosis 2006; 185: 320-326.
230. Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. 2009. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009; 26: 447-455.
231. O'Donovan A, Hughes BM, Slavich GM, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 2010; 24: 1074-1077.
232. Carroll JE, Low CA, Prather AA, et al. Negative affective responses to a speech task predict changes in inter-leukin (IL)-6. Brain Behav Immun 2011; 25: 232-238.
233. Bercik P, Verdu EF, Foster JA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-2112.
234. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 2008; 118: 2209-2218.
235. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 2004; 130: 355-391.
236. Mendes WB, Blascovich J, Hunter SB, Lickel B, Jost JT. Threatened by the unexpected: physiological responses during social interactions with expectancy-violating partners. J Pers Soc Psychol 2007; 92: 698-716.
237. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002; 16: 622-653.
238. Padgett DA, Glaser R. How stress influences the immune response. Trends Immun 2003; 24: 444-8.
239. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-328.
240. Thayer JF, Loerbroks A, Sternberg EM. Inflammation and cardiorespiratory control: the role of the vagus nerve. Respir Physiol Neurobiol 2011; 178: 387-394.
241. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immu-nosup-pression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290.
242. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19: 203-214.
243. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873-904.
244. Buffalari DM, Grace AA. Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation. J Neurosci 2007; 27: 12358-12366.
245. McEwen BS. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 2010; 1204: E38-E59.
246. McEwen BS, Eiland L, Hunter RG, Miller MM. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012; 62: 3-12.
247. McNally L, Bhagwagr Z, Hannestad J. Inflammation, glutamate and glia in depression. CNS spectr 2008; 13: 501-510.
248. Salim S, Asghar M, Taneja M, et al. Potential contribution of oxidative stress and inflammation to anxiety and hypertension. Brain Res 2011; 1404: 63-71.
249. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
250. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
251. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003; 21: 315-325.
252. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
253. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16: 238-246.
254. O'Donovan A, Pantell MS, Puterman E, et al. Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One 2011; 6: e19687.
255. Ader R, Felten DL, Cohen N. Psychoneuroimmunology. 2nd ed. San Diego: Academic Press 2001.
256. Irwin MR, Miller A. Depressive disorders and immunity: 20 years of progress and discover. Brain Behav Immun 2007; 21: 374-383.
257. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 1999; 77: 769-780.
258. Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol 2011; 46: 90-95.
259. Arranz L, De Vicente A, Muñoz M, De la Fuente M. Impairment immune function in homeless population with stress-related disorders. Neuroimmunomodulation 2009; 16: 251-260
260. Viveros MP, Arranz L, Hernanz A, Miquel J, De la Fuente M. A model of premature aging in mice based on altered stress-related behavioral response and immunosenescence. Neuroimmunomodulation 2007; 14: 157-162.
261. De la Fuente M, Gimenez-Llort L. Models of aging of neuroimmunomodulation: strategies for its improvement. Neuroimmunomodulation 2010; 17: 213-216.
262. De la Fuente M. Murine models of premature ageing for the study of diet-induced immune changes: improvement of leucocyte functions in two strains of old prematurely ageing mice by dietary supplementation with sulphur-containing antioxidants. Proc Nutr Soc 2010; 69: 651-659.
263. Vida C, De la Fuente M. Stress-related behavioural responses, immunity and ageing in animal models. Immunosenescence. In: Bosch JA, Phillips C, Lord JM, Eds. Immunosenescence: Psychosocial and behavioral determinants. Media New York: Springer 2013; pp. 125-144.
264. Guayerbas N, Catalán M, Victor VM, Miquel J, De la Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res 2002; 134: 41-48.
265. Guayerbas N, Puerto M, Fernández MD, De la Fuente M. A diet supplemented with thiolic anti-oxidants improves leukocyte function in two strains of prematurely ageing mice. Clin Exp Pharmacol Physiol 2002; 29: 1009-1014.
266. Guayerbas N, De la Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Comp Immunol 2003, 27: 339-350.
267. Gilad GM, Gilad VH. Strain, stress, neurodegeneration and longevity. Mech Ageing Dev 1995; 78: 75-83.
268. Viveros MP, Fernández B, Guayerbas N, De la Fuente M. Behavioral characterization of a mouse model of premature immunosenescence. J Neuroimmunol 2001; 114: 80-88.
269. Carlsson A. Brain neurotransmitters in normal and pathological aging. The biological substrates of Alzheimer's disease. In: Schei-bel AB, Wechsler AF, Brazier MAB, Eds. UCLA Forum in Medical Sciences, Orlando: Academic Press 1986; pp: 193-203.
270. Katzman R, Terry R. Normal aging of the nervous system. In: Katzman R, Rowe JW, Eds. Principles of Geriatric Neurology. Philadephia: FA Davis 1992; pp: 18-58.
271. Makman MH. Influence of normal aging on monoamines, monoamine receptors and associated signal transduction systems. In: Makman MH, Stefano GB, Eds. Neuroregulatory Mechanisms in Aging. Oxford: Pergamon Press 1993; pp: 47-78.
272. Magnone MC, Rossolini G, Piantanelli L, Migani P. Neurochemical parameters of the main neurotransmission systems in aging mice. Arch Gerontol Geriatr 2000; 30: 269-279.
273. De la Fuente M, Hernanz A, Medina S, Guayerbas N, Fernández B, Viveros MP. Characterization of monoaminergic systems in brain regions of prematurely ageing mice. Neurochem Int 2003; 43: 165-172.
274. McNeill TH, Koek LL, Haycock TW. The nigrostriatal system and aging. Peptides 1984; 5: 263-268.
275. File SE, Kenny PJ, Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 2000; 66: 65-72.
276. Graeff FG, Guimarães FS, De Andrade TG, Deakin FW. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 129-141.
277. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551-555.
278. Henry JP, Wang S. Effects of early stress on adult affiliative behavior. Psychoneuroendocrinology 1998; 23: 863-875
279. Pérez-Álvarez L, Baeza I, Arranz L, et al. Behavioral, endocrine and immunological characteristics of a murine model of premature aging. Dev Comp Immunol 2005; 29: 965-976.
280. Mitra R, Sapolsky RM. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hyperthophy. PNAS 2008; 105: 5573-5578.
281. Bauer ME, Muller GC, Correa BL, Vianna P, Turner JE, Bosch JA. Psychoneuroendocrine interventions aimed at attenuating immu-nosenescence: a review. Biogerontology 2013; 14: 9-20.
282. Bauer ME. Chronic stress and immunosenescence: a review. Neu-roimmunomodulation 2008; 15: 241-250.
283. Puerto M, Guayerbas N, Víctor V, De la Fuente M. Effects of N-acetylcysteine on macrophage and lymphocyte functions in a mouse model of premature ageing. Pharmacol Biochem Behav 2002; 73: 797-804.
284. Alvarado C, Álvarez P, Jiménez L, De la Fuente, M. Oxidative stress in leukocytes from young prematurely aging mice is reversed by supplementation with biscuits rich in antioxidants. Dev Comp Immunol 2006; 30: 1168-1180.
285. Alvarado C, Álvarez P, Puerto M, et al. Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition 2006; 22: 767-777.
286. De la Fuente M, Miñano M, Victor VM, et al. Relation between exploratory activity and immune function in aged mice: a preliminary study. Mech Ageing Dev 1998; 102: 263-277.
287. Gouin JP, Hantsoo L, Kiecolt-Glaser JK. Immune dysregulation and chronic stress among older adults: a review. Neuroimmuno-modulation 2008; 15: 251-259.
288. Vida C, Rodríguez-Terés S, Heras V, Corpas I, De la Fuente M, González E. The aged-related increase in xanthine oxidase expression and activity in several tissues from mice is not shown in long-lived animals. Biogerontology 2011; 12: 551-564
289. Vida C, De Castro NM, Corpas I, De la Fuente M, González E. Changes in xanthine oxidase activity and lipid peroxidation levels in prematurely aging mice. Acta Physiol Scand 2009; 195: 100-101.
290. Manassra R, Vida C, Sainz de Aja JG, De la Fuente M. In prematurely aging mice with anxiety the decrease of spleen antioxidant defences in comparison with control animals disappears with age. Neuroimmunomodulation 2011; 18: 391.